Ascletis Pharma Inc. (HKG:1672)

Ascletis Pharma Revenue

In the year 2025, Ascletis Pharma had annual revenue of 2.03M CNY with 58.07% growth. Ascletis Pharma had revenue of 947.00K in the half year ending December 31, 2025, a decrease of -90.61%.

• Revenue: 2.03M CNY
• Revenue Growth: +58.07%
• P/S Ratio: 5,427.30
• Revenue / Employee: 10.04K CNY
• Employees: 202
• Market Cap: 12.25B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.03M	745.00K	58.07%
Dec 31, 2024	1.28M	-55.31M	-97.73%
Dec 31, 2023	56.60M	2.51M	4.63%
Dec 31, 2022	54.09M	-22.79M	-29.64%
Dec 31, 2021	76.88M	41.88M	119.64%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 2, 2026

Data Sources Report a data error